Literature DB >> 30430578

Single-cell sequencing defines genetic heterogeneity in pancreatic cancer precursor lesions.

Yuko Kuboki1, Catherine G Fischer1, Violeta Beleva Guthrie2,3, Wenjie Huang1, Jun Yu4, Peter Chianchiano1, Waki Hosoda1, Hao Zhang5, Lily Zheng2,6, Xiaoshan Shao2,3, Elizabeth D Thompson1,7, Kevin Waters1, Justin Poling1, Jin He4, Matthew J Weiss4, Christopher L Wolfgang4, Michael G Goggins1,7, Ralph H Hruban1,7, Nicholas J Roberts1, Rachel Karchin2,3,7, Laura D Wood1,7.   

Abstract

Intraductal papillary mucinous neoplasms (IPMNs) are precursors to pancreatic cancer; however, little is known about genetic heterogeneity in these lesions. The objective of this study was to characterize genetic heterogeneity in IPMNs at the single-cell level. We isolated single cells from fresh tissue from ten IPMNs, followed by whole genome amplification and targeted next-generation sequencing of pancreatic driver genes. We then determined single-cell genotypes using a novel multi-sample mutation calling algorithm. Our analyses revealed that different mutations in the same driver gene frequently occur in the same IPMN. Two IPMNs had multiple mutations in the initiating driver gene KRAS that occurred in unique tumor clones, suggesting the possibility of polyclonal origin or an unidentified initiating event preceding this critical mutation. Multiple mutations in later-occurring driver genes were also common and were frequently localized to unique tumor clones, raising the possibility of convergent evolution of these genetic events in pancreatic tumorigenesis. Single-cell sequencing of IPMNs demonstrated genetic heterogeneity with respect to early and late occurring driver gene mutations, suggesting a more complex pattern of tumor evolution than previously appreciated in these lesions.
Copyright © 2018 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd. Copyright © 2018 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Keywords:  genetic heterogeneity; intraductal papillary mucinous neoplasm; pancreatic cancer precursor lesion; single-cell sequencing; somatic mutation

Mesh:

Substances:

Year:  2019        PMID: 30430578      PMCID: PMC6368872          DOI: 10.1002/path.5194

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  22 in total

1.  Intraductal Papillary Mucinous Neoplasms Arise From Multiple Independent Clones, Each With Distinct Mutations.

Authors:  Catherine G Fischer; Violeta Beleva Guthrie; Alicia M Braxton; Lily Zheng; Pei Wang; Qianqian Song; James F Griffin; Peter E Chianchiano; Waki Hosoda; Noushin Niknafs; Simeon Springer; Marco Dal Molin; David Masica; Robert B Scharpf; Elizabeth D Thompson; Jin He; Christopher L Wolfgang; Ralph H Hruban; Nicholas J Roberts; Anne Marie Lennon; Yuchen Jiao; Rachel Karchin; Laura D Wood
Journal:  Gastroenterology       Date:  2019-06-05       Impact factor: 22.682

2.  Is the Early Detection of Pancreatic Cancer Possible? It Is Good News, Bad News.

Authors:  Ralph H Hruban
Journal:  Pancreas       Date:  2019 May/Jun       Impact factor: 3.327

3.  Pancreatic cancer: why we must be optimistic?

Authors:  Philip A Philip
Journal:  Cancer Metastasis Rev       Date:  2021-09       Impact factor: 9.264

Review 4.  Early detection of pancreatic cancer using DNA-based molecular approaches.

Authors:  Aatur D Singhi; Laura D Wood
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-06-07       Impact factor: 46.802

5.  PhyDOSE: Design of follow-up single-cell sequencing experiments of tumors.

Authors:  Leah L Weber; Nuraini Aguse; Nicholas Chia; Mohammed El-Kebir
Journal:  PLoS Comput Biol       Date:  2020-10-01       Impact factor: 4.475

Review 6.  The cellular origins of cancer with particular reference to the gastrointestinal tract.

Authors:  Malcolm R Alison
Journal:  Int J Exp Pathol       Date:  2020-08-14       Impact factor: 1.925

Review 7.  An analysis of genetic heterogeneity in untreated cancers.

Authors:  Johannes G Reiter; Marina Baretti; Jeffrey M Gerold; Alvin P Makohon-Moore; Adil Daud; Christine A Iacobuzio-Donahue; Nilofer S Azad; Kenneth W Kinzler; Martin A Nowak; Bert Vogelstein
Journal:  Nat Rev Cancer       Date:  2019-08-27       Impact factor: 60.716

8.  THBS2/CA19-9 Detecting Pancreatic Ductal Adenocarcinoma at Diagnosis Underperforms in Prediagnostic Detection: Implications for Biomarker Advancement.

Authors:  Shirsa Udgata; Naomi Takenaka; William R Bamlet; Ann L Oberg; Stephanie S Yee; Erica L Carpenter; Daniel Herman; Jungsun Kim; Gloria M Petersen; Kenneth S Zaret
Journal:  Cancer Prev Res (Phila)       Date:  2020-10-16

Review 9.  The genetics of ductal adenocarcinoma of the pancreas in the year 2020: dramatic progress, but far to go.

Authors:  Elizabeth D Thompson; Nicholas J Roberts; Laura D Wood; James R Eshleman; Michael G Goggins; Scott E Kern; Alison P Klein; Ralph H Hruban
Journal:  Mod Pathol       Date:  2020-07-23       Impact factor: 7.842

10.  Multiregion whole-exome sequencing of intraductal papillary mucinous neoplasms reveals frequent somatic KLF4 mutations predominantly in low-grade regions.

Authors:  Kohei Fujikura; Waki Hosoda; Matthäus Felsenstein; Qianqian Song; Johannes G Reiter; Lily Zheng; Violeta Beleva Guthrie; Natalia Rincon; Marco Dal Molin; Jonathan Dudley; Joshua D Cohen; Pei Wang; Catherine G Fischer; Alicia M Braxton; Michaël Noë; Martine Jongepier; Carlos Fernández-Del Castillo; Mari Mino-Kenudson; C Max Schmidt; Michele T Yip-Schneider; Rita T Lawlor; Roberto Salvia; Nicholas J Roberts; Elizabeth D Thompson; Rachel Karchin; Anne Marie Lennon; Yuchen Jiao; Laura D Wood
Journal:  Gut       Date:  2020-10-07       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.